Client Login      

Medicus International has been successfully delivering high quality medical education programmes to US, EU and Asia Pacific based global pharmaceutical and biotech clients for over 35 years. We develop inspired strategic solutions through an understanding of market opportunities and trends, product differentiation and required target audience reach. This philosophy has established us as experts in defining global communications strategies that deliver brand success.




The lifecycle of your brand

Find out more about careers with Medicus International

See the therapy areas in which have expertise

 

    Medicus International on LinkedIn 

 
 
Forbion raises €190 million for new funds *** MorphoSys signs hospital infection research deal with Absynth *** 2010 Scrip Awards shortlist announced *** <i>NEJM</i> editorial pans Abbott's obesity drug Merida *** Pharma needs to be wary of new "biopiracy" moves in Africa *** Greece delays price bulletin because "data need to be checked" *** Pfizer updates Tygacil label with increased mortality risk *** Ipsen to acquire rights to Santhera's fipamezole *** UK "could be throwing away up to £100 million a year on unused drugs" *** Pharma firms face cancer drug fund uncertainty in the UK *** Roche mulls costs and staff cuts by year end *** Takeda deal for Contrave sets stage for US obesity showdown *** Eisai takes novel Alzheimer's antibody into the clinic *** Pfizer to bolster rare disease portfolio with FoldRx acquisition *** India throws rule book at 'superbug' scientists *** Index appoints Johnson partner *** New investor leads Celator's $20 million series D *** Relief for Dendreon on upcoming US Medicare coverage meeting on Provenge *** Scottish biotech companies combine *** Henderson Morley files notice of administration ***
Copyright 2010 by Medicus International